Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.35
-0.23 (-3.50%)
At close: Nov 10, 2025, 4:00 PM EST
6.35
0.00 (0.00%)
After-hours: Nov 10, 2025, 4:10 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $299.94 million as of November 10, 2025. Its market cap has decreased by -64.43% in one year.
Market Cap
299.94M
Enterprise Value
202.18M
1-Year Change
-64.43%
Ranking
Category
Stock Price
$6.35
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $299.94M, a decrease of -44.29%. That is a compound annual growth rate of -10.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 310.80M | -4.32% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |